Table 1.
Demographic characteristics and screening test scores.
| Group | N | Age (years) | Male (%) | HY (stage) | Education (years) | LEDD (mg) | MMSE score | MoCA score |
|---|---|---|---|---|---|---|---|---|
| PD-NC | 32 | 68.6 (8.8) | 63 | 2.5 (0.6) | 13.0 (2.4) | 700 (475) | 29.3 (0.7) | 27.8 (1.2) |
| PD-MCI | 23 | 70.9 (8.2) | 65 | 2.6 (0.8) | 12.9 (1.4) | 725 (314) | 28.1 (1.5) | 24.4 (1.4) |
| PD-D | 8 | 70.5 (5.9) | 75 | 3.1 (1.3) | 12.8 (1.8) | 450 (397) | 24.6 (2.1) | 17.6 (2.6) |
PD-NC, PD patients with MoCA score ≥26; PD-MCI, PD patients with MoCA score 21–25; PD-D, PD patients with MoCA score <21; MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; HY, Hoehn and Yahr stage; LEDD, levodopa equivalent daily dose.